Agnos Biosciences
PrivateLast Round
Grant
Feb 2, 2026
Company Overview
Agnos Biosciences is a biotechnology company that developed AirSeq, a technology for rapid and accurate detection of airborne biological material.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring, Threat Intelligence
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agnos Biosciences Comps
Public and private peers based on sector, stage, and business model.
Agnos Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 2, 2026 |
Agnos Biosciences Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Received funding from BBSRC, DARPA, Earlham Institute, and Natural History Museum.
Agnos Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Agnos Biosciences's valuation, stock price, and market status.
